SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Frostman who wrote (8871)6/2/1998 8:52:00 AM
From: Zebra 365  Read Replies (1) of 23519
 
The agency said Viagra's active substance, sildenafil citrate, should not be prescribed to patients who are taking nitrates, have recently had a stroke or heart attack or suffer from low blood pressure, severe heart or liver problems or certain inherited eye diseases. It added that it should not be used by women.>>

Hmmm

Sounds like %50 of the true ED market is going to be excluded, as the paper presented yesterday suggested that 70% of men with organic ED had it based on vascular disease.

Zebra
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News